Yi Shan Li

Yi Shan Li

61 Jahre
Health Technology
Consumer Services
Finance

Profil

Yi Shan Li is the founder of Blossomhill Therapeutics, Inc., founded in 2020, holding the title of Executive Chairman since 2020.
Dr. Li was the founder of Turning Point Therapeutics, Inc., founded in 2013, and held the title Head-TP Therapeutics Asia in 2019.
Former jobs include Director at SABiosciences Corp.
from 2002 to 2009, Executive Vice President at Epitomics, Inc. from 2008 to 2013, Member at the University of California, Berkeley, Principal at RBC Capital Markets LLC, Vice President at Kenson Ventures LLC from 2001 to 2003, and Principal at Santa Cruz Biotechnology, Inc. Education history includes a doctorate from The Ohio State University conferred in 1994, an MBA from the University of California, Berkeley conferred in 2001, and an undergraduate degree from the University of Science & Technology of China conferred in 1987.

Aktive Positionen von Yi Shan Li

UnternehmenPositionBeginn
BLOSSOMHILL THERAPEUTICS, INC. Gründer 01.06.2020

Ehemalige bekannte Positionen von Yi Shan Li

UnternehmenPositionEnde
TURG POIN Vorstandsvorsitzender 01.09.2018
Corporate Officer/Principal 30.04.2013
Direktor/Vorstandsmitglied 31.12.2009
Private Equity Investor 31.12.2003
Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Yi Shan Li im Detail an

Ausbildung von Yi Shan Li

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

92

Beziehungen ersten Grades

10

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen10

Health Technology

Health Technology

Consumer Services

Consumer Services

Finance

Finance

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Yi Shan Li